Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ultragenyx Pharmaceu (RARE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,315,187
  • Shares Outstanding, K 51,279
  • Annual Sales, $ 51,500 K
  • Annual Income, $ -197,610 K
  • 60-Month Beta 2.21
  • Price/Sales 68.75
  • Price/Cash Flow N/A
  • Price/Book 5.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -1.74
  • Number of Estimates 8
  • High Estimate -1.57
  • Low Estimate -1.86
  • Prior Year 0.62
  • Growth Rate Est. (year over year) -380.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.23 +9.15%
on 02/26/19
70.35 -8.10%
on 03/18/19
+4.83 (+8.07%)
since 02/22/19
3-Month
37.44 +72.68%
on 12/24/18
70.35 -8.10%
on 03/18/19
+25.76 (+66.24%)
since 12/21/18
52-Week
37.44 +72.68%
on 12/24/18
90.98 -28.94%
on 09/25/18
+13.29 (+25.88%)
since 03/22/18

Most Recent Stories

More News
Why Is Ultragenyx (RARE) Up 12.4% Since Last Earnings Report?

Ultragenyx (RARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

RARE : 64.65 (-6.36%)
51.3% Return Seen to Date on SmarTrend Ultragenyx Pharm Call (RARE)

SmarTrend identified an Uptrend for Ultragenyx Pharm (NASDAQ:RARE) on January 8th, 2019 at $44.98. In approximately 2 months, Ultragenyx Pharm has returned 51.29% as of today's recent price of $68.05....

RARE : 64.65 (-6.36%)
Uptrend Call Working As Ultragenyx Pharm Stock Rises 47.9% (RARE)

SmarTrend identified an Uptrend for Ultragenyx Pharm (NASDAQ:RARE) on January 8th, 2019 at $44.98. In approximately 2 months, Ultragenyx Pharm has returned 47.91% as of today's recent price of $66.53....

RARE : 64.65 (-6.36%)
Ultragenyx to Present at Upcoming Investor Conferences

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that it will present...

RARE : 64.65 (-6.36%)
Ultragenyx Pharm Rises 3.16% on Heavy Volume: Watch For Potential Pullback

Ultragenyx Pharm (NASDAQ:RARE) traded in a range yesterday that spanned from a low of $65.59 to a high of $66.75. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high...

RARE : 64.65 (-6.36%)
Ultragenyx Announces Proposed Public Offering of Common Stock

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that it has commenced...

RARE : 64.65 (-6.36%)
JPM : 99.76 (-3.02%)
Look for Shares of Ultragenyx Pharm to Potentially Pullback after Yesterday's 7.29% Rise

Ultragenyx Pharm (NASDAQ:RARE) traded in a range yesterday that spanned from a low of $61.00 to a high of $64.68. Yesterday, the shares gained 7.3%, which took the trading range above the 3-day high...

RARE : 64.65 (-6.36%)
33.0% Return Seen to Date on SmarTrend Ultragenyx Pharm Call (RARE)

SmarTrend identified an Uptrend for Ultragenyx Pharm (NASDAQ:RARE) on January 8th, 2019 at $44.98. In approximately 2 month, Ultragenyx Pharm has returned 32.99% as of today's recent price of $59.82.

RARE : 64.65 (-6.36%)
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia

DTX401 Response in Time to Hypoglycemia and Improved Glucose Control Maintained or Improved in All Three Patients

RARE : 64.65 (-6.36%)
Report: Exploring Fundamental Drivers Behind Canopy Growth, Adobe, Ultragenyx Pharmaceutical, Humana, Ship Finance International, and NexGen Energy -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy Growth Corporation (NYSE:CGC),...

HUM : 272.60 (-1.50%)
RARE : 64.65 (-6.36%)
ADBE : 259.69 (-1.70%)
SFL : 12.12 (-2.02%)
NXGEF : 2.4274 (+4.02%)
NXE : 1.66 (-2.92%)
CGC : 44.38 (-3.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade RARE with:

Business Summary

Ultragenyx Pharmaceutical Inc. is involved in the identification, acquisition, development and commercialization of products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating metabolic genetic diseases. The Company's product pipeline include KRN23 (UX023)...

See More

Key Turning Points

2nd Resistance Point 70.35
1st Resistance Point 67.50
Last Price 64.65
1st Support Level 63.18
2nd Support Level 61.71

See More

52-Week High 90.98
Fibonacci 61.8% 70.53
Last Price 64.65
Fibonacci 50% 64.21
Fibonacci 38.2% 57.89
52-Week Low 37.44

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar